Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical β-lactam antibiotic therapy be improved?-Reference-Cited by-同舟云学术

Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical β-lactam antibiotic therapy be improved?

Published:2007-11 Issue:5 Volume:30 Page:458-462
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Bhat Sunil,Fujitani Shigeki,Potoski Brian A.,Capitano Blair,Linden Peter K.,Shutt Kathleen,Paterson David L.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference7 articles.

1. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem–cilastatin. The Severe Pneumonia Study Group;Fink;Antimicrob Agents Chemother,1994

2. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use;Neuhauser;JAMA,2003

3. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth Informational Supplement. Wayne, PA: NCCLS; 2004.

4. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial;Chastre;JAMA,2003

5. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription;Singh;Am J Respir Crit Care Med,2000

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical predictors of mortality in patients with pseudomonas aeruginosa infection;PLOS ONE;2023-04-28

2. Development of a combination antibiogram for empirical treatments of Pseudomonas aeruginosa at a university-affiliated teaching hospital;Journal of Microbiology, Immunology and Infection;2023-04

3. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?;Expert Review of Anti-infective Therapy;2023-03-08

4. Retrospective comparative study of Pseudomonas aeruginosa antibiotic resistance isolated from intensive care units (ICUs) patients from tertiary hospital in Nepal;Journal of Microbiology & Experimentation;2022-04-20

5. A phenotypic and molecular investigation of biofilm formation in clinical samples of Pseudomonas aeruginosa;MOL BIOL RES COMMUN;2021